Filing Flows › Bio-Rad Laboratories (BIO) › Free cash flow
Bio-Rad Laboratories (BIO) free cash flow by quarter
Bio-Rad Laboratories' free cash flow was $65.2M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $65.2M (Q3 2026) to $119M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $65.2M | -2% | -27% |
| Q2 2026 | $66.7M | -15% | -6% |
| Q1 2026 | $78.1M | -34% | -18% |
| Q4 2025 | $119M | +34% | — |
| Q3 2025 | $89.2M | +26% | — |
| Q2 2025 | $70.8M | -26% | — |
| Q1 2025 | $95.5M | — | — |
Q3 2026 at a glance
Bio-Rad Laboratories, Q3 2026: revenue $656M (+0.5% year over year), operating margin -7.6%, net earnings $459M, operating cash flow $96.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio-Rad Laboratories' free cash flow?
Bio-Rad Laboratories' free cash flow was $65.2M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Bio-Rad Laboratories' free cash flow changed?
Over the last 7 quarters it ranged from $65.2M (Q3 2026) to $119M (Q4 2025).